Cencora Inc (COR)

Industry Medical Distribution
This stock can be held in an Investment ISA and an Investment Account
Sell

$291.60

Buy

$291.79

arrow-down$-0.915 (-0.31%)

AmerisourceBergen Corp is a pharmaceutical services company. It provides drug distribution and related healthcare services and solutions to pharmacy, physician, and manufacturer customers based in the United States and Canada.
Prices updated at 20 May 2025, 20:13 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.72%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Distribution
Chairman
Mr. Steven H. Collis
CEO
Mr. Robert P. Mauch
Most recent earnings
30 Sep 2024
Fiscal year end
30 Sep 2024
Employees
46,000
Head office
1 West First Avenue
Conshohocken
United States
19428-1800
mobile
+1 610 727-7000
letter
Bennett.Murphy@cencora.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Dermot Mark Durcan
Lead Independent Director
0.13m--0.38m-
Mr. Lon R. Greenberg
Independent Director
0.12m--0.32m-
Mr. Steven H. Collis
Executive Chairman of the Board
1.46m--18.48m-
Mr. James F. Cleary, Jr
Executive Vice President and Chief Financial Officer
0.89m--9.00m-
Ms. Ornella Barra
Director
-----
Mr. Werner Baumann
Independent Director
0.15m--0.44m-
Mr. Lazarus Krikorian
Senior Vice President and Chief Accounting Officer
-----
Mr. Robert P. Mauch
Director, President and Chief Executive Officer
1.04m--9.25m-
Dr. Lorence H. Kim, M.D.
Independent Director
0.12m--0.32m-
Mr. Dennis M. Nally
Independent Director
0.18m--0.38m-
Mr. Frank K. Clyburn, Jr
Independent Director
-----
Ms. Lauren M. Tyler
Independent Director
0.14m--0.34m-
Ms. Silvana Battaglia
Executive Vice President and Chief Human Resources Officer
0.63m--5.32m-
Ms. Elizabeth S. Campbell
Executive Vice President and Chief Legal Officer
0.72m--7.67m-
Dr. Redonda G. Miller, M.B.A.
Independent Director
0.15m--0.35m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc21,353,3800.10736514020.24130230 Apr 202511.02
Walgreens Boots Alliance Inc19,980,00091.89792--30 Apr 202510.31
Walgreens Boots Alliance Holdings LLC19,980,000-19980000-30 Apr 202510.19
BlackRock Inc17,991,8950.1050915862519.66893530 Apr 20259.29
T. Rowe Price Associates, Inc.8,859,4520.22947780660.88899430 Apr 20254.57

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
31 Dec 2024-Ms. Silvana Battaglia190.988,55820,374--
31 Dec 2024-Ms. Elizabeth S. Campbell190.9810,16218,792--
20 Dec 2024-Ms. Silvana Battaglia228.72383,79220,329--
18 Dec 2024-Mr. Steven H. Collis--322,308--
18 Dec 2024-Mr. Steven H. Collis232.2491,735321,913--
18 Dec 2024-Mr. Steven H. Collis--9,474--
18 Dec 2024-Mr. James F. Cleary, Jr232.2448,074149,293--
18 Dec 2024-Mr. James F. Cleary, Jr--6,043--
18 Dec 2024-Mr. James F. Cleary, Jr--149,500--
18 Dec 2024-Mr. Lazarus Krikorian--22,096--
18 Dec 2024-Mr. Lazarus Krikorian--3,285--
18 Dec 2024-Mr. Lazarus Krikorian232.2425,08221,988--
18 Dec 2024-Mr. Robert P. Mauch--53,603--
18 Dec 2024-Mr. Robert P. Mauch--18,948--
18 Dec 2024-Mr. Robert P. Mauch232.24183,23752,814--
03 Dec 2024-Mr. Lazarus Krikorian250.41454,75421,988--
27 Nov 2024-Mr. James F. Cleary, Jr89.583,034,702171,508--
27 Nov 2024-Mr. James F. Cleary, Jr-----
27 Nov 2024-Mr. James F. Cleary, Jr249.075,533,090149,293--
25 Nov 2024-Mr. Steven H. Collis--321,913--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.